Unternehmen Clarmin Explorations Inc. Toronto S.E.
Aktien
A2QJAV
CA23256X1006
CYBN
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Douglas Drysdale
CEO | Chief Executive Officer | 54 | 01.08.20 |
Paul Glavine
FOU | Founder | 35 | 13.10.16 |
Eric So
FOU | Founder | 49 | 13.10.16 |
Greg Cavers
DFI | Director of Finance/CFO | 54 | 05.11.20 |
Alex Nivorozhkin
CTO | Chief Tech/Sci/R&D Officer | 64 | 01.12.20 |
Ryan Richardson
CTO | Chief Tech/Sci/R&D Officer | - | - |
Amir Inamdar
CTO | Chief Tech/Sci/R&D Officer | - | 01.10.21 |
Alexander Belser
CTO | Chief Tech/Sci/R&D Officer | - | 01.10.20 |
Lori Challenger
ADM | Chief Administrative Officer | - | - |
Aaron Bartlone
COO | Chief Operating Officer | - | 01.12.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Eric So
FOU | Founder | 49 | 13.10.16 |
Mark Lawson
BRD | Director/Board Member | 52 | 05.11.20 |
Grant Froese
BRD | Director/Board Member | 62 | 05.11.20 |
Director/Board Member | - | 16.08.21 | |
George Tziras
BRD | Director/Board Member | 43 | 23.10.23 |
Eric Hoskins
BRD | Director/Board Member | 63 | 05.11.20 |
Paul Glavine
FOU | Founder | 35 | 13.10.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 759 692 495 | 693 272 166 ( 91,26 %) | 0 | 91,26 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+9.99% | 115 Mrd. | |
+12.01% | 106 Mrd. | |
-3.07% | 24.69 Mrd. | |
-0.67% | 21.97 Mrd. | |
-4.59% | 19.27 Mrd. | |
-6.90% | 17.56 Mrd. | |
-39.36% | 17.32 Mrd. | |
+5.82% | 14.03 Mrd. | |
+33.05% | 12.13 Mrd. |